AMSTERDAM, the Netherlands—For hemodynamically stable patients with STEMI and multivessel coronary artery disease, those who receive immediate complete revascularization fare just as well as those who ...

Intervening on significant nonculprit lesions in addition to the culprit lesion in patients with STEMI and multivessel PCI improves hard clinical outcomes, an updated meta-analysis shows. And a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Primary PCI should continue to be the standard of care ...

Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Antiplatelet therapy with ticagrelor after primary PCI ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...

SAN DIEGO, CA — A large trial in patients with acute coronary syndrome (ACS), including patients with and without ST-segment elevation MI (NSTEMI and STEMI), shows that a coronary intervention ...

It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...

(DAPT) in patients treated with Firehawk stents was non-inferior to 12 months of DAPT for the primary composite event of ...

Antithrombotic therapy during percutaneous coronary intervention for ST-segment elevation myocardial infarction has evolved substantially over the past 15 years. With the results of the ATOLL trial, ...